Smartphone Application for Asthma Management
Trial Summary
What is the purpose of this trial?
The primary goal of this project is to determine the feasibility, acceptability, and adherence of a smartphone application for improving asthma self-management in a pilot randomized controlled trial (RCT). The app is specifically designed to appeal to adolescents. Adolescents with persistent asthma will be randomized to receive: 1) standard-of-care or 2) the self-management app in addition to standard-of-care. Feasibility will be assessed by the ability to recruit and retain subjects, technical barriers to implementation, and the appropriateness of the intervention among adolescents and providers. The acceptability of the intervention will be determined by appraising perceived usefulness, entertainment, and ease of use of the app. Adherence to usage of the app over a 6-month period will be assessed by examining the frequency of app usage and the features that were used, and the extent of data regarding self-management that was entered. A secondary objective is to obtain preliminary estimates of effectiveness of the app on clinical outcomes (ACT score, spirometry, CHSA-C, exacerbations, and medication adherence) relative to standard-of-care. It is hypothesized that the app will result in a high level of adherence and will be a feasible and acceptable intervention to improve self-management among adolescents with persistent asthma.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. It seems you will continue with your standard asthma care while using the app.
What data supports the effectiveness of the treatment Asthma SMART, Asthma Self-Management Apps, Asthma SMART Systems for asthma management?
Research shows that self-management programs, which can be delivered through smartphone apps, are recommended by major clinical guidelines and have been associated with improved outcomes for asthma patients. These apps offer customizable, low-cost, and accessible ways to support asthma management, potentially improving patient adherence and outcomes.12345
Is the Smartphone Application for Asthma Management safe for humans?
How is the Asthma SMART treatment different from other asthma treatments?
Asthma SMART is unique because it uses a smartphone app designed to help patients manage their asthma by providing personalized, user-centered tools and information. Unlike traditional treatments, it includes a wireless spirometer (a device to measure lung function) that helps patients self-assess their condition, making it easier to manage asthma at home or on the go.710111213
Research Team
Marisa Couluris, DO
Principal Investigator
University of South Florida
Paul Rosen, PhD
Principal Investigator
University of Utah
Amy Alman, PhD
Principal Investigator
University of South Florida
Eligibility Criteria
This trial is for English-speaking adolescents aged 12-17 with mild to severe persistent asthma, who own an iPhone or Android device. They must be diagnosed by clinic physicians and live in the Tampa Bay area during the trial. It's not for those with other chronic lung diseases, certain disorders like cystic fibrosis, vision impairments that affect app use, mental or developmental disorders impacting self-management, or those involved in the app's development.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the self-management app daily for asthma management in addition to standard-of-care
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Asthma SMART
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Florida
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator